ggillesp.bsky.social
@ggillesp.bsky.social
Reposted
A big part of the CIO team will be at #BSI2025 🤓 especially now that our very own Max from the @ggillesp.bsky.social lab is featured on the conference poster! Looking forward to an exciting few days in Liverpool 🔬✨ #Immunology #CIOonTour
🚨 Abstract submissions are OPEN for the British Society for Immunology Congress 2025! #BSI25

Join 1,500+ immunologists in Liverpool between 1–4 Dec, for 4 days of science, workshops & networking.

Submit your abstract by 3 Sept & showcase your research! 🔗 bit.ly/4kYXvLN
June 26, 2025 at 10:09 AM
Reposted
Great to see our review of the immunomodulatory role of cytomegalovirus and the relationship with cancer and immune checkpoint blockade treatment published as an open access article in the Philosophical Transactions of the Royal Society:

royalsocietypublishing.org/doi/10.1098/...
The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy | Philosophical Transactions of the Royal Society B: Biological Sciences
This review discusses the role of chronic human cytomegalovirus (HCMV) infection in patients receiving immune checkpoint blockade (ICB) treatment against different malignancies, with an especial focus on malignant melanoma. We briefly outline the impact ...
royalsocietypublishing.org
November 6, 2025 at 6:10 PM
Reposted
Atom-level mechanism of tapasin-independent peptide editing by Major Histocompatibility Complex class I molecules https://www.biorxiv.org/content/10.1101/2025.06.20.660712v1
June 25, 2025 at 9:16 PM